Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

ClinicalTrials.gov ID: NCT03570749

Public ClinicalTrials.gov record NCT03570749. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 2, 2026, 12:13 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to select up to two doses of baricitinib (referred to as low dose and high dose) and assess their efficacy and safety for the treatment of severe or very severe alopecia areata. An additional subpopulation of 60 participants in the US will enroll in the open-label addenda.

Study identification

NCT ID
NCT03570749
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
784 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 24, 2018 (Actual)
Primary completion
Feb 2, 2021 (Actual)
Completion
Jan 29, 2025 (Actual)
Last update posted
Apr 16, 2026

2018 – 2025

United States locations

U.S. sites
50
U.S. states
21
U.S. cities
44
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
Coastal Clinical Research, Inc Mobile Alabama 36608 —
Johnson Dermatology Fort Smith Arkansas 72916 —
California Dermatology & Clinical Research Institute Encinitas California 92024 —
Alliance Research Centers Irvine California 92612 —
University of CA, Irvine Irvine California 92617 —
Dermatology Research Associates Los Angeles California 90045 —
Stanford Health Care Redwood City California 94063 —
University of California Davis-Dermatology Sacramento California 95816 —
University Clinical Trials, Inc. San Diego California 92123 —
Mosaic Dermatology Santa Monica California 90403 —
Yale University School of Medicine New Haven Connecticut 06519 —
Solutions Through Advanced Research, Inc. Jacksonville Florida 32256 —
University of Miami Miami Florida 33125 —
Park Avenue Dermatology Orange Park Florida 32073 —
ForCare Clinical Research Tampa Florida 33613-1244 —
Skin Care Physicians of Georgia Macon Georgia 31217 —
Medaphase Inc Newnan Georgia 30263 —
Northwestern University Chicago Illinois 60611 —
Forefront Research Louisville Kentucky 40241 —
Callender Center for Clinical Research, LLC / Research Glenn Dale Maryland 20769 —
ActivMed Practices and Research Beverly Massachusetts 01915 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Clarkston Skin Research Clarkston Michigan 48346 —
University of Minnesota Medical School Minneapolis Minnesota 55455 —
ActivMed Practices and Research Portsmouth New Hampshire 03801 —
University of Rochester School of Medicine Rochester New York 14642 —
Montefiore Medical Center The Bronx New York 10467-2490 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
OH State Univ College of Med Gahanna Ohio 43230 —
NW Dermatology & Research Center, LLC Portland Oregon 97210 —
Oregon Medical Research Center Portland Oregon 97223 —
OHSU Center for Health and Healing Portland Oregon 97239 —
Dermatology and Skin Surgery Center Exton Pennsylvania 19341 —
Penn State Univ. Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Dermatology Associates of Plymouth Meeting Plymouth Meeting Pennsylvania 19462 —
Medical University of South Carolina Charleston South Carolina 29425 —
Bellaire Dermatology Bellaire Texas 77401 —
Modern Research Associates Dallas Texas 75231 —
Center for Clinical Studies Houston Texas 77004 —
Austin Institute for Clinical Research Pflugerville Texas 78660 —
Texas Dermatology and Laser Specialists San Antonio Texas 78218 —
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229 —
Center for Clinical Studies Webster Texas 77598 —
University of Utah MidValley Dematology Murray Utah 84107 —
Dermatology Associates Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03570749, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2026 · Synced Nov 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03570749 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →